Grace Therapeutics Inc
Grace Therapeutics Inc (GRCE) Historical Volatility
GRCE 30-day historical volatility is 40%. This ranks in the 46th percentile of readings over the past year.
Read more
Tracking GRCE historical volatility helps you see how much Grace Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Grace Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor GRCE 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The GRCE 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Grace Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Grace Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where GRCE HV is running hot, cold, or in line. Make the GRCE 30 day historical volatility — and every other window — work for your edge instead of against it.
As of October 21, 2026
As of October 21, 2026
See how volatility has moved over time
Track GRCE historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→